Recombinant microbial ADP-ribosylating toxins of Bordetella pertussis, Vibrio cholerae, and enterotoxigenic Escherichia coli: structure, function, and toxoid vaccine development.
Burnette
W N
WN
Molecular Pharmaceutics Corporation, Westlake Village, California.
Cieplak
W
W
Kaslow
H R
HR
Rappuoli
R
R
Tuomanen
E I
EI
D036002:ADP Ribose Transferases / Q000096:biosynthesis* / Q000737:chemistry / Q000502:physiology; D001427:Bacterial Toxins / Q000096:biosynthesis* / Q000737:chemistry; D001886:Bordetella pertussis / Q000235:genetics / Q000378:metabolism; D002772:Cholera Toxin / Q000096:biosynthesis* / Q000737:chemistry; D004768:Enterotoxins / Q000096:biosynthesis* / Q000737:chemistry; D004926:Escherichia coli / Q000235:genetics / Q000378:metabolism; D029968:Escherichia coli Proteins; D005818:Genetic Engineering; D037342:Pertussis Toxin; D010567:Pertussis Vaccine / Q000096:biosynthesis*; D011994:Recombinant Proteins / Q000096:biosynthesis*; D014614:Vaccines, Synthetic / Q000096:biosynthesis*; D010566:Virulence Factors, Bordetella / Q000096:biosynthesis / Q000737:chemistry
D001427:Bacterial Toxins; D004768:Enterotoxins; D029968:Escherichia coli Proteins; D010567:Pertussis Vaccine; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; D010566:Virulence Factors, Bordetella; D002772:Cholera Toxin; C027538:heat-labile enterotoxin, E coli; D036002:ADP Ribose Transferases; D037342:Pertussis Toxin